Physician
Integrated Regional Laboratories Pathology Services, LLC
Integrated Regional Laboratories Pathology Services, LLC was paid $162K by Medicaid between Jan 2021 and Nov 2024, across 82 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 13% of everything it billed.
33Billing provider infoINTEGRATED REGIONAL LABORATORIES PATHOLOGY SERVICES, LLC
PANAMA CITY, FL 32405
PANAMA CITY, FL 32405
33aNPI1023684065assigned 06/01/2021
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$162K
24GClaims138,940
24DCodes billed82
24AFirst – last monthJan 2021 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#58 of 207
Median peer was paid$39K
This provider vs. median4.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RODKEY, JOHN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 14,515 | $9K | |
| 2022 | 25,485 | $33K | |
| 2023 | 47,358 | $64K | |
| 2024incomplete | 51,582 | $56K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 13% | 16,106 | 10,912 | $21K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9.9% | 2,280 | 2,067 | $16K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 8.7% | 191 | 175 | $14K |
| 85027 | 7.7% | 22,935 | 13,594 | $13K | |
| 87430 | 5.0% | 5,406 | 5,052 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.6% | 4,206 | 3,347 | $7K |
| 87040 | 4.5% | 2,339 | 2,034 | $7K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.8% | 298 | 264 | $6K |
| 81025 | 3.2% | 3,402 | 3,127 | $5K | |
| 84484 | 3.0% | 4,159 | 3,242 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.8% | 1,807 | 1,686 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.5% | 3,658 | 1,718 | $4K |
70 more codes
| 83735 | 2.5% | 8,202 | $4K | |
| 84702 | 2.1% | 1,293 | $3K | |
| 83605 | 1.7% | 2,357 | $3K | |
| 87400 | 1.5% | 1,440 | $2K | |
| 84703 | 1.4% | 1,634 | $2K | |
| 80061 | Lipid panel | 1.4% | 839 | $2K |
| 81001 | 1.3% | 7,697 | $2K | |
| 86920 | 1.3% | 188 | $2K | |
| 83880 | 1.2% | 1,159 | $2K | |
| 87420 | 1.1% | 917 | $2K | |
| 87077 | <1% | 1,143 | $1K | |
| 86850 | <1% | 2,532 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 228 | $1K |
| 83690 | <1% | 2,459 | $1K | |
| 87088 | <1% | 1,761 | $1K | |
| 85730 | <1% | 1,724 | $1K | |
| 86880 | <1% | 1,140 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,369 | $1K |
| 86900 | <1% | 4,399 | $978.16 | |
| 87081 | <1% | 1,537 | $978.03 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 142 | $902.14 |
| 88307 | <1% | 15 | $873.90 | |
| 86140 | <1% | 2,449 | $872.17 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,033 | $797.45 |
| 86901 | <1% | 3,891 | $782.99 | |
| 87186 | <1% | 602 | $743.96 | |
| 81003 | <1% | 3,478 | $735.41 | |
| 82247 | <1% | 1,331 | $678.74 | |
| 84439 | <1% | 1,120 | $641.25 | |
| 84100 | <1% | 1,928 | $600.10 | |
| 80320 | <1% | 183 | $512.42 | |
| 85610 | <1% | 1,788 | $449.62 | |
| 86592 | <1% | 1,816 | $431.95 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 361 | $418.11 |
| 82728 | <1% | 210 | $401.62 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 144 | $396.25 |
| 87070 | <1% | 467 | $296.81 | |
| 83615 | <1% | 760 | $296.46 | |
| 82248 | <1% | 687 | $286.64 | |
| 82150 | <1% | 501 | $280.48 | |
| 80202 | <1% | 71 | $247.47 | |
| 84550 | <1% | 732 | $226.16 | |
| 82570 | <1% | 300 | $192.57 | |
| 80069 | <1% | 233 | $181.31 | |
| 84156 | <1% | 673 | $168.57 | |
| 82607 | <1% | 78 | $158.17 | |
| 80076 | <1% | 160 | $153.99 | |
| 85651 | <1% | 470 | $144.50 | |
| 83540 | <1% | 235 | $126.70 | |
| 82140 | <1% | 68 | $121.58 | |
| 83550 | <1% | 127 | $92.86 | |
| 85045 | <1% | 252 | $83.56 | |
| 85379 | <1% | 96 | $80.86 | |
| 82550 | <1% | 115 | $78.48 | |
| 87205 | <1% | 117 | $77.92 | |
| 85378 | <1% | 125 | $68.75 | |
| 80074 | <1% | 12 | $64.21 | |
| 82746 | <1% | 30 | $63.95 | |
| 87075 | <1% | 29 | $61.15 | |
| 86803 | <1% | 38 | $53.73 | |
| 82540 | <1% | 360 | $40.73 | |
| 85014 | <1% | 326 | $32.13 | |
| 87340 | <1% | 46 | $32.08 | |
| 84132 | <1% | 112 | $24.24 | |
| 86870 | <1% | 13 | $20.44 | |
| 87045 | <1% | 13 | $19.99 | |
| 85018 | <1% | 353 | $19.97 | |
| 82009 | <1% | 13 | $7.02 | |
| 84112 | 0% | 20 | $0.00 | |
| 89051 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRODKEY, JOHN (OWNER/VP OF OPERATIONS)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.